LynxCare, founded in 2016, is a pioneering company headquartered in Belgium, operating at the intersection of AI and Health Care. Their mission, encapsulated by the slogan "Unlocking Clinical Outcomes & Real-World Evidence at scale," underscores their focus on precision medical data. The company leverages EHR-derived insights from a federated hospital network to provide high-quality, validated, and cNLP-enriched medical data.
Utilizing a secure European infrastructure, LynxCare aims to offer real-world medical data that stakeholders across the healthcare sector can trust. The company recently secured a €20.00M Series A investment on 21 June 2022 from a consortium of investors, including Elaia, Matterwave Ventures, MTIP, PMV, b2venture, and HERAN Partners. These funds signal strong investor confidence, reinforcing the company's potential to revolutionize the medical data landscape through its innovative AI solutions.